1. Outcome after PORT in ypN2 or R1/R2 versus no PORT in ypN0 Stage III-N2 NSCLC after Induction Chemotherapy and Resection 
Charlotte Billiet, MD, Stéphanie Peeters, MD, PhD, Herbert Decaluwé, MD, Johan Vansteenkiste, MD, PhD, Christophe Dooms, MD, PhD, Christophe M. Deroose, MD, PhD, Marc Hendrikx, MD, PhD, Paul De Leyn, MD, PhD, Paul Bulens, MD, Rezaul Karim, MD, Cécile Le Péchoux, MD, Jeroen Mebis, MD, PhD, Dirk De Ruysscher, MD, PhD 
Journal of Thoracic Oncology 
Volume 11, Issue 11, Pages (November 2016)
DOI: /j.jtho
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

2. Figure 1
Patient inclusion algorithm. PORT, postoperative radiotherapy.
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

3. Figure 2
Changes compared with baseline of clinical parameters (dyspnea and cough) and lung function parameters (forced expiratory volume in 1 second [FEV1] and diffusing capacity of the lung for carbon monoxide [Dlco]) in follow-up in the postoperative radiotherapy (PORT) versus non-PORT groups (per-protocol analysis). Acute post-RT means 3 months or less after start of radiotherapy RT, and late post-RT means 12 months or less after start RT.
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions